Single‐Cell RNA Sequencing Reveals LEF1 as a Prognostic Biomarker for Poor Outcomes in Oxaliplatin‐Resistant Colorectal Cancer
Human Mutation · 2025
DOI: 10.1155/humu/6705599 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Mutation, 2025. Verfasst von Pin Huang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, The Affiliated Zhangjiagang Hospital of Soochow University, Suzhou, Jiangsu, China. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Oxaliplatin, Drug Resistance, Neoplasm, Biomarkers, Tumor. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Colorectal cancer (CRC) is a leading cause of cancer‐related morbidity and mortality worldwide. Despite the efficacy of oxaliplatin‐based chemotherapy (CT) in CRC treatment, CT resistance remains a major obstacle to successful patient outcomes. Epithelial–mesenchymal transition (EMT), a key cellular process in cancer metastasis, plays a pivotal role in resistance to CT. The tumor microenvironment (TME), particularly cancer‐associated fibroblasts (CAFs), is known to contribute to EMT and therapy resistance. Here, we employ single‐cell RNA sequencing (scRNA‐seq) to analyze primary CRC tumor samples from patients undergoing CT and nonchemotherapy (nCT) treatments. Our study identifies specific epithelial cell clusters resistant to oxaliplatin, elucidating the molecular pathways involved in EMT and resistance. Furthermore, we explore the role of CAF subpopulations in promoting resistance within the TME. Our findings highlight the importance of functional immune profiling and genomic analyses in identifying potential biomarkers for predicting CT responses and improving personalized treatment strategies. This work provides new insights into the molecular mechanisms of oxaliplatin resistance in CRC and supports the development of novel immune‐based therapeutic approaches to enhance patient outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of General Surgery, The Affiliated Zhangjiagang Hospital of Soochow University, Suzhou, Jiangsu, China.
- Department of General Surgery, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
ORCID-Profile: Xiagang Luo, Hubin Xu
Zitieren
APA
Huang, P., Guo, K., Tu, J., Fang, J., Zhou, L., Luo, X., & Xu, H. (2025). Single‐Cell RNA Sequencing Reveals LEF1 as a Prognostic Biomarker for Poor Outcomes in Oxaliplatin‐Resistant Colorectal Cancer. Human Mutation. https://doi.org/10.1155/humu/6705599
Vancouver
Huang P, Guo K, Tu J, Fang J, Zhou L, Luo X, et al. Single‐Cell RNA Sequencing Reveals LEF1 as a Prognostic Biomarker for Poor Outcomes in Oxaliplatin‐Resistant Colorectal Cancer. Human Mutation. 2025. doi:10.1155/humu/6705599
BibTeX
@article{Huang2025,
author = {Huang, Pin and Guo, Ke and Tu, Jiancheng and Fang, Jian and Zhou, Liang and Luo, Xiagang and Xu, Hubin},
title = {Single‐Cell RNA Sequencing Reveals LEF1 as a Prognostic Biomarker for Poor Outcomes in Oxaliplatin‐Resistant Colorectal Cancer},
journal = {Human Mutation},
year = {2025},
doi = {10.1155/humu/6705599}
}
EUVIMED